Organisations from across the community pharmacy sector, who have joined together to look into the future modelling of pharmacy practice, have held their third meeting to advance discussions.
The group discussed the issue of supervision, and what any change in associated legislation and guidance may look like, and how any such change must benefit patients through greater access to care and services and enable the profession to thrive within a future health and care system that enable pharmacy to deliver a holistic range of patient care and support.
During the session, which was largely run on a workshop format, members of the group explored what aspects of community pharmacy practice supervision should apply to, and the core principles underpinning supervision that needed to be considered. The group also worked through a number of scenarios to test emerging thinking in this space.
Chair of the group, Dr Michael Twigg, Associate Professor of Primary Care Pharmacy, University of East Anglia, said “It is really positive that the sector bodies are working collaboratively and effectively to think about what the future of supervision legislation and guidance will look like. Our continued focus is to ensure any future proposals on supervision are fit for purpose for all concerned”.
The group will meet again on 23rd March 2023, when the group will start to firm up some of the finer detail of the proposals. The aim of the group is to produce recommendations to the DHSC and regulators for consultation across the wider profession and sector.
If you would like further information on this work, then please contact your local organisational representative in the first instance.
The Pharmacy Supervision Practice Group is made up of the following members:
- AIMP Limited (AIMP)
- Association of Pharmacy Technicians United Kingdom (APTUK)
- Company Chemists’ Association Limited (CCA)
- National Pharmacy Association Limited (NPA)
- Pharmacists’ Defence Association (PDA)
- Pharmacy Forum Northern Ireland (PFNI)
- The Royal Pharmaceutical Society of Great Britain (RPS)
Observers on the Group are:
- General Pharmaceutical Council (GPhC)
- Department of Health and Social Care (DHSC)
- Pharmaceutical Society of Northern Ireland (PSNI)
Learn more
- Supervision group hold second meeting
- PDA is representing interests of employed and locum pharmacists in supervision group
- PDA Chairman, Mark Koziol presenting to the 2020 Sigma conference about supervision
- Why Covid-19 has shown that remote supervision can never be supported
- It’s time to kill off the remote supervision concept
- Government respond to anti remote supervision petition to keep pharmacists present for patients
- PDA fights to stop the threat of remote supervision
- PDA response to leaked DoH document on supervision of medicines supply by pharmacy technicians
Not yet a PDA member?
If you have not yet joined the PDA, we encourage you to join today and ask your colleagues to do the same.
Membership is FREE to pharmacy students, trainee pharmacists and for the first three months of being newly qualified.
Read about our key member benefits here.